Companies
Discover all trending biotech companies
Discover all trending biotech companies
Company Research Platform
Annual Revenue
$ 2,500,000,000
Global Employees
12,000
R&D Investment
115900000
This segment focuses on the research, development, manufacturing, and distribution of dental implant systems and prosthetic solutions. Straumann offers a wide range of dental implants, including tissue and bone level implants, as well as titanium, ceramic, and mini-implant systems. Research and development activities include surface treatments to enhance osseointegration, innovative implant designs for improved stability, and advanced materials like Roxolid. The segment also provides prosthetic solutions such as abutments, crowns, and bridges, utilizing CAD/CAM technology for precision and esthetics. Patient impact is significant, as these products restore oral function and improve the quality of life for patients with missing teeth. Straumann holds a leading market position due to its strong brand reputation, extensive product portfolio, and commitment to innovation. Future opportunities include expanding into new markets, developing advanced implant materials, and integrating digital workflows. Regulatory aspects involve rigorous testing and approval processes to ensure product safety and efficacy. Partnerships with dental professionals and laboratories are crucial for successful product adoption and patient outcomes.
This segment encompasses the development, manufacturing, and marketing of orthodontic solutions, with a particular focus on clear aligner systems. Straumann's ClearCorrect aligners offer a discreet and effective alternative to traditional braces. Research and development efforts are directed towards improving aligner materials, optimizing treatment planning software, and enhancing patient comfort and predictability. The segment utilizes advanced 3D printing and digital scanning technologies to create customized aligners. Therapeutic areas include the correction of malocclusion and the improvement of dental alignment. Patient impact is substantial, as clear aligners provide a cosmetic and convenient option for achieving straighter teeth. Straumann's competitive advantage lies in its integration of digital workflows, strong distribution network, and commitment to clinical education. Future opportunities include expanding the aligner product portfolio, integrating AI-driven treatment planning, and increasing market penetration. Regulatory considerations involve compliance with medical device regulations and clinical validation of treatment outcomes. Partnerships with orthodontists and dental practices are essential for successful patient treatment and market growth.
This segment focuses on providing digital solutions for dental professionals and laboratories, encompassing intraoral scanners, CAD/CAM software, 3D printers, and milling machines. Straumann's digital platform integrates various technologies to streamline workflows, improve precision, and enhance patient outcomes. Research and development activities include the development of advanced scanning technologies, AI-powered treatment planning tools, and materials for digital fabrication. The segment supports various therapeutic areas, including implant dentistry, prosthetics, and orthodontics. Patient impact is significant, as digital solutions enable more accurate diagnoses, predictable treatment outcomes, and improved patient experiences. Straumann's market position is strengthened by its comprehensive digital ecosystem, strong partnerships with technology providers, and commitment to training and education. Future opportunities include expanding the digital product portfolio, integrating AI and machine learning, and developing cloud-based platforms for data management and collaboration. Regulatory aspects involve compliance with medical device regulations and data privacy standards. Partnerships with dental practices, laboratories, and technology providers are crucial for successful market adoption and innovation.